Structural dynamics of the human androgen receptor: implications for prostate cancer and neurodegenerative disease

J Duff1, P Davies, K Watt

  • 1School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, Scotland, UK.

Insights

The androgen receptor (AR) is crucial for male development and its gene alterations cause disorders like prostate cancer. Studying AR gene mutations, particularly in the ligand-binding and N-terminal domains, is key to understanding these diseases.

Area of Science:

  • Molecular Biology
  • Genetics
  • Endocrinology

Background:

  • The androgen receptor (AR) is a transcription factor mediating steroid hormone action.
  • AR gene alterations are linked to androgen insensitivity, prostate cancer, and Kennedy's disease.

Purpose of the Study:

  • To investigate the structural dynamics and genetic changes in the AR.
  • To understand the mechanisms of AR action in disease pathogenesis.

Main Methods:

  • Analysis of AR gene mutations in patients with prostate cancer and Kennedy's disease.
  • Characterization of genetic alterations in the AR's ligand-binding domain (LBD) and N-terminal domain (NTD).

Main Results:

  • Mutations in the AR gene, especially in the LBD and NTD, are critical for receptor function.
  • Structural dynamics play a significant role in AR-mediated signaling and disease.

Conclusions:

  • Understanding AR structural dynamics and mutations is vital for developing treatments for AR-related disorders.
  • Further research into AR genetic changes will illuminate disease mechanisms.

Related Concept Videos

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Internal Receptors01:31

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...